Drug intelligence / Profile preview

autologous endothelial progenitor cells

Development stage
Phase 2
Lead developer
BioGenCell
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Autologous endothelial progenitor cells (EPCs) are primitive bone marrow cells that have the capacity to proliferate, migrate, and differentiate into mature endothelial cells that line the lumen of blood vessels. These cells are harvested from a patient's own bone marrow or peripheral blood, expanded ex vivo, and then reinfused intravenously. EPCs possess both stem cell and endothelial cell characteristics, gradually losing stem cell properties while gaining endothelial cell features during maturation. They are typically identified by surface markers including CD34, CD133, and VEGFR-2 (vascular endothelial growth factor receptor-2). EPCs participate in neovascularization and vascular repair processes, making them potential therapeutic agents for various ischemic and vascular conditions.

Other names
EPCsautologous EPCs

Beyond the preview

Go deeper on autologous endothelial progenitor cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous endothelial progenitor cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call